XML 53 R5.htm IDEA: XBRL DOCUMENT v2.4.1.9
Condensed Consolidated Statements of Cash Flows (Unaudited) (USD $)
 3 Months Ended
Mar. 31, 2015
Mar. 31, 2014
Cash Flows from Operating Activities    
Net loss $ (2,418,404)us-gaap_NetIncomeLoss $ (2,070)us-gaap_NetIncomeLoss
Depreciation and amortization 77,242us-gaap_DepreciationAndAmortization 0us-gaap_DepreciationAndAmortization
Amortization of debt issuance cost 27,321us-gaap_AmortizationOfFinancingCostsAndDiscounts   
Stock based compensation expense 12,000us-gaap_ShareBasedCompensation   
Amortization of debt discount 2,089,005us-gaap_AmortizationOfDebtDiscountPremium   
Changes in operating assets and liabilities:    
Accounts receivable 981,574us-gaap_IncreaseDecreaseInAccountsReceivable   
Inventory (48,940)us-gaap_IncreaseDecreaseInInventories   
Prepaid expense (40,272)us-gaap_IncreaseDecreaseInPrepaidExpense   
Accounts payable and accrued liabilities (184,304)us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities 1,500us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
Net cash provided by (used in) operating activities 495,221us-gaap_NetCashProvidedByUsedInOperatingActivities (570)us-gaap_NetCashProvidedByUsedInOperatingActivities
Cash Flows from Investing Activities    
Payments for acquisition of fixed assets (1,654)us-gaap_PaymentsToAcquirePropertyPlantAndEquipment   
Payments for acquisition of Factor Nutrition Labs (4,500,000)us-gaap_PaymentsForProceedsFromOtherInvestingActivities   
Net cash used in investing activities (4,501,654)us-gaap_NetCashProvidedByUsedInInvestingActivities   
Cash Flows from Financing Activities    
Proceeds from notes payable     
Payment of debt issuance cost (289,045)us-gaap_PaymentsOfDebtIssuanceCosts  
(Repayments to) advances from related party notes 11,184us-gaap_ProceedsFromRepaymentsOfRelatedPartyDebt   
Warrant exercise 1us-gaap_PaymentsForHedgeFinancingActivities   
Net cash provided by financing activities 5,722,140us-gaap_NetCashProvidedByUsedInFinancingActivities   
Net increase in cash and cash equivalents 1,715,707us-gaap_CashAndCashEquivalentsPeriodIncreaseDecrease (570)us-gaap_CashAndCashEquivalentsPeriodIncreaseDecrease
Cash and Cash Equivalents, beginning of period 338us-gaap_CashAndCashEquivalentsAtCarryingValue 3,230us-gaap_CashAndCashEquivalentsAtCarryingValue
Cash and Cash Equivalents, end of period 1,716,045us-gaap_CashAndCashEquivalentsAtCarryingValue 2,660us-gaap_CashAndCashEquivalentsAtCarryingValue
Cash paid during the period for:    
Interest      
Income taxes      
Supplemental Disclosure of Non-cash Investing and Financing Activities:    
Common stock issued for settlement of debt 100,000us-gaap_ConversionOfStockAmountConverted1   
Beneficial conversion feature on warrants issued concurrent with debt 3,415,514us-gaap_DebtConversionConvertedInstrumentAmount1   
Assumption of liabilities as part of acquisition transaction 9,332,559us-gaap_LiabilitiesAssumed1   
Note issued as part of asset purchase agreement $ 1,500,000us-gaap_StockIssuedDuringPeriodValueAcquisitions